Home Newsfeeds Income Opportunity Realty Q2 EPS $0.20, Same YoY

Income Opportunity Realty Q2 EPS $0.20, Same YoY

Income Opportunity Realty (AMEX:IOR) reported quarterly earnings of $0.20 per share. This is unchanged from the same period last year.

byMichael Horton

August 12, 2022

1 minute read

Income Opportunity Realty (AMEX:IOR) reported quarterly earnings of $0.20 per share. This is unchanged from the same period last year.

Hello Group And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

By Avi Kapoor

May 28, 5:45 AM

U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining around 0.5% on Tuesday. Shares…

AXSM

Cresco Labs Co-Founder Comments On $25M First Tranche Financing Of Psychedelics-Focused REIT

By Javier Hasse

June 18, 1:24 PM

Healing Realty Trust (HRT), formerly known as Healing Commercial Real Estate Inc., has announced the successful closure of the first tranche (undisclosed amount) of its $25 million Series A funding round.

CRLBF

As Small Caps Lag 20% Behind S&P 500, Reddit User Says Market Cap Definitions ‘Should Really Be Readjusted For Inflation’

By Surbhi Jain

June 17, 9:22 AM

Reddit users discuss adjusting market cap definitions to account for inflation. Small-cap value stocks lag behind S&P 500, prompting calls for change.

SLYV

Catalyst Pharmaceuticals Announces Multiple Abstracts On FYCOMPA From Eisai Co, Ltd., To Be Presented At The 35th International Epilepsy Congress

By Happy Mohamed

August 14, 8:49 AM

Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for

CPRX

Income Opportunity Realty Q2 EPS $0.20, Same YoY

Related Posts

Hello Group And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

Cresco Labs Co-Founder Comments On $25M First Tranche Financing Of Psychedelics-Focused REIT

As Small Caps Lag 20% Behind S&P 500, Reddit User Says Market Cap Definitions ‘Should Really Be Readjusted For Inflation’

Catalyst Pharmaceuticals Announces Multiple Abstracts On FYCOMPA From Eisai Co, Ltd., To Be Presented At The 35th International Epilepsy Congress